Viral Arthritis

Slide 1 · Viral Arthritis

Clinical pathology · mechanisms · diagnostic reasoning

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish arthralgia from objective arthritis and identify urgent nonviral differentials.

Explain direct infection and infection-triggered immune mechanisms of synovitis.

Compare characteristic parvovirus, hepatitis, rubella and alphavirus syndromes.

Select targeted viral investigations using exposure, symptoms and test timing.

Slide 3 · What Robbins establishes

Viral infections can produce acute or subacute arthritis.

Major agents: Alphaviruses, parvovirus B19, rubella, Epstein–Barr virus, hepatitis B and C.

Joint inflammation can reflect direct viral infection or an immune response triggered by infection.

Slide 4 · Why this diagnosis matters

Acute viral arthritis can resemble early rheumatoid arthritis.

Several viral syndromes are self-limited; Hepatitis-associated disease may require pathogen-directed management.

Missing bacterial septic arthritis is more dangerous than overtesting an uncomplicated viral syndrome.

Clinical and exposure history determines which viral tests are useful.

Slide 5 · Arthralgia is not synonymous with arthritis

Finding

Arthralgia

Clinical arthritis

Core feature

Joint pain

Objective synovial inflammation

Examination

May have no swelling

Swelling, effusion, warmth and/or restricted motion

Implication

Can accompany systemic viraemia

Requires evaluation for inflammatory or infectious causes

Slide 6 · Three presentations to recognize

Pattern

Characteristic setting

Principal challenge

Abrupt symmetric polyarthritis

Parvovirus B19 or acute hepatitis B

Distinguish from early RA

Febrile polyarthralgia after mosquito exposure

Chikungunya or other alphavirus

Differentiate dengue and other febrile illnesses

Subacute or persistent arthropathy

HCV or post-chikungunya symptoms

Look for immune-mediated disease and alternative diagnoses

Slide 7 · Agent groups in the Robbins list

Virus/group

Typical clinical association

Important clue

Parvovirus B19

Acute RA-like symmetric arthropathy

Contact with young children

Alphaviruses

Febrile arthralgia/arthritis

Geographic and mosquito exposure

HBV / HCV

Arthritis with systemic viral infection

Hepatic and immune-complex features

Rubella / EBV

Arthropathy with systemic illness

Rash/adenopathy or mononucleosis syndrome

Slide 8 · Exposure directs the differential

Context / findings

Childcare, school outbreak or household child with rash

Consider parvovirus B19

Diagnostic implication

Recent mosquito exposure or compatible travel

Consider chikungunya and locally circulating arboviruses

Slide 9 · Time course is a diagnostic clue

Onset/course

Interpretation

Caution

Hours to days; Marked febrile illness

Consider arbovirus or invasive joint infection

Do not dismiss septic arthritis

Days to weeks; New symmetric small-joint symptoms

Consider parvovirus B19 or HBV prodrome

Early RA may appear similar

Persistent or relapsing symptoms

Chikungunya sequelae, HCV, or primary rheumatic disease

Reassess original viral attribution

Slide 10 · Two broad pathways to joint inflammation

Viral infection

Direct infection

Viral entry or persistence in joint-associated tissues can produce local inflammation.

Immune-mediated injury

Antigens and host responses activate inflammatory pathways without requiring persistent synovial infection.

These are mechanisms—not a reliable bedside classification of every virus.

Slide 11 · Direct infection: The conceptual sequence

Viral exposure

Systemic infection

Joint access

In selected infections

Local response

Synovial inflammation

Clinical phenotype

Pain · swelling

Rubella and some alphavirus infections as examples of direct joint infection.

Slide 12 · Indirect inflammation: Immune pathway

Viral antigens

During infection

Host response

Antibody / immune cells

Inflammation

Immune-complex or cytokine effects

Synovitis

Arthritis

A viral trigger can cause inflammatory joint disease even without proof of joint viral replication.

Slide 13 · Immune complexes explain a clinical trap

Viral antigen–antibody complexes can activate complement and inflammatory pathways.

In hepatitis B, prodromal arthritis is a recognized immune-complex phenomenon.

Immune-complex activation may coexist with rash, hypocomplementemia or other extra-articular findings.

A compatible syndrome does not require demonstration of virus inside synovium.

Slide 14 · Autoantibody positivity is not proof of RA

Transient rheumatoid factor and antinuclear antibodies may occur in acute viral arthritis.

Low-titre positivity must be interpreted in clinical context and over time.

Persistent synovitis, erosions and disease-specific serology increase concern for primary inflammatory arthritis.

Do not initiate long-term immunosuppression from a single nonspecific serology result.

Slide 15 · Synovial morphology is often nonspecific

Uninflamed synovium (schematic)

Joint cavity

Thin synovial lining

Inflamed synovium (schematic)

Joint cavity

Thickened inflamed lining

Schematic: Synovial inflammatory changes are not specific for a particular virus.

Slide 16 · The systemic syndrome gives etiologic clues

Rash and recent child exposure: Consider parvovirus B19.

Pre-icteric malaise, rash and polyarthritis: Consider acute hepatitis B.

Mosquito exposure with acute fever and severe polyarthralgia: Consider chikungunya.

Purpura, neuropathy or renal disease with chronic HCV: Consider cryoglobulinemic vasculitis.

Slide 17 · Parvovirus B19: Clinical context

A common human DNA virus that may cause erythema infectiosum and arthropathy.

Outbreak or household exposure to young children supports consideration.

Adults may develop joint symptoms without a classic rash.

Infection also has important hematologic and pregnancy implications.

Slide 18 · Parvovirus arthritis in adults

Symmetric inflammatory pain commonly affects wrists, MCP and PIP joints.

The acute pattern can closely mimic early rheumatoid arthritis.

Symptoms are commonly transient, but some patients have prolonged joint complaints.

Systemic features can be mild or absent when arthritis dominates.

Slide 19 · Children and adults differ in joint pattern

Feature

Children

Adults

Predominant pattern

Often oligoarticular

Often symmetric polyarticular

Common involvement

Knee or larger joints

Hands, wrists, knees and feet

Associated signs

Erythema infectiosum may be conspicuous

Classic rash may be absent

Diagnostic issue

Recognize viral illness

Avoid mistaken RA diagnosis

Slide 20 · Parvovirus rash: Helpful but not required

The “slapped cheek” facial eruption is characteristic of erythema infectiosum.

A reticular or lacy truncal/extremity rash may occur.

Joint symptoms can occur independently of cutaneous signs, particularly in adults.

Absence of rash cannot exclude recent parvovirus infection.

Slide 21 · Parvovirus B19: Immune association

Acute B19 infection

Antiviral antibodies

Immune activation

Transient synovitis

The association of arthritis with the antibody response supports an immune-mediated contribution; Mechanisms remain incompletely resolved.

Slide 22 · Testing for recent parvovirus infection

B19-specific IgM supports recent infection in a compatible clinical syndrome.

B19 IgG alone commonly reflects previous exposure, not the cause of current arthritis.

PCR can be relevant in selected immunocompromised or hematologic settings.

Choose testing on clinical probability rather than reflexive viral panels.

Slide 23 · Parvovirus: Vulnerable patient groups

Chronic hemolytic conditions: Infection may precipitate a transient aplastic crisis.

Immunocompromised hosts: Persistent infection can produce chronic anemia.

Pregnancy: Maternal infection can lead to fetal complications.

These risks influence assessment even when articular disease appears mild.

Slide 24 · Acute hepatitis B may begin with arthritis

Symmetric polyarthritis can precede jaundice or recognition of hepatitis.

Rash, malaise, fever and myalgia can accompany this serum-sickness-like syndrome.

Small joints and ankles/knees may be involved.

Arthritis may improve as the clinically apparent hepatitis phase begins.

Slide 25 · Hepatitis B: Immune-complex model

Circulating HBV antigens

Antibody binding

Immune-complex activation

Rash and polyarthritis

Complement consumption may accompany this process; The diagram represents an accepted mechanism, not a patient measurement.

Slide 26 · Hepatitis B: Timing of manifestations

Early acute infection

Viral antigens present

Prodromal period

Arthritis · rash · malaise

Clinical hepatitis

Jaundice may emerge

Joint improvement

Common clinical course

The sequence is typical, not obligatory: Not every HBV infection produces jaundice or arthritis.

Slide 27 · HBV workup must identify infection status

Interpret HBsAg, anti-HBc and other HBV serology together, not in isolation.

HBV DNA may be used to establish or characterize ongoing infection.

Abnormal transaminases may prompt evaluation, but normal values do not alone exclude infection.

Serologic interpretation and management follow current hepatology practice.

Slide 28 · HBV-related arthritis versus early RA

Feature

Acute HBV-associated arthritis

Rheumatoid arthritis

Temporal pattern

Abrupt prodromal illness

Typically sustained inflammatory disease

Extra-articular clues

Rash, malaise, hepatitis context

Disease-specific systemic associations

Joint damage

Often resolves without erosion

Erosions can develop in uncontrolled disease

Decisive step

HBV testing with clinical correlation

Longitudinal rheumatologic assessment

Slide 29 · HCV: Arthritis is only one manifestation

Chronic HCV infection can produce joint symptoms through sustained immune stimulation.

Associated syndromes include mixed cryoglobulinemia, vasculitis and sicca symptoms.

Joint disease may be subtle relative to systemic manifestations.

Detection matters because antiviral management can alter the disease course.

Slide 30 · Two HCV-associated articular patterns

Pattern

RA-like arthritis

Cryoglobulinemic syndrome

Joints

Symmetric small-joint polyarthritis

Often medium/large-joint oligoarthritis

Systemic clues

May lack overt vasculitis

Purpura, neuropathy, renal involvement

Damage

Often nonerosive

Usually nonerosive articular disease

Assessment

HCV infection plus RA differential

HCV RNA, cryoglobulins and complement

Slide 31 · HCV: Chronic immune stimulation

Chronic HCV infection

B-cell stimulation

Cryoglobulin production

Immune-complex injury

Cryoglobulinemic vasculitis affects vessels and may coexist with arthralgia or arthritis.

Slide 32 · Cryoglobulinemia: Recognize more than joints

Palpable purpura is an important clue to small-vessel involvement.

Peripheral neuropathy or renal abnormalities increase concern for systemic vasculitis.

Serum complement, particularly C4, may be reduced.

HCV testing is clinically relevant when this constellation is present.

Slide 33 · HCV diagnosis: Infection plus syndrome

Screen for HCV antibodies according to clinical indication; Confirm current infection with HCV RNA.

Order cryoglobulins and complement in an appropriate vasculitic phenotype.

Cryoglobulin specimens require appropriate laboratory collection/handling.

Do not infer active HCV infection from rheumatoid factor positivity.

Slide 34 · Rheumatoid factor can mislead in HCV

Marker

What it can indicate

Why it is insufficient

Rheumatoid factor

Can occur in RA or HCV-associated disorders

Poor specificity in an infected patient

Anti-CCP / ACPA

Supports RA when phenotype fits

Not perfect; Consider complete clinical context

HCV RNA

Current HCV infection

Does not prove HCV caused every joint symptom

C4 / cryoglobulins

Support an immune-complex syndrome

Require correlation with systemic findings

Slide 35 · Alphaviruses: Arthritogenic examples

Virus

Epidemiologic context

Clinical theme

Chikungunya

Aedes mosquito transmission; Multiple regions

Abrupt fever and severe arthralgia

Ross River

Australia and nearby regions

Febrile illness, rash and polyarthritis

Sindbis

Parts of Europe, Africa and Asia

Fever, rash and arthralgia

Mayaro

Parts of tropical South America

Febrile arthralgia/arthritis

Slide 36 · Chikungunya: Striking acute presentation

Acute onset of fever with severe bilateral or symmetric polyarthralgia.

Small and large joints may be involved; Swelling can occur.

Myalgia, rash, headache and conjunctival symptoms may coexist.

Recent residence or travel in an area with transmission is diagnostically important.

Slide 37 · Chikungunya: Acute to persistent symptoms

Mosquito exposure

Acute febrile phase

Severe joint pain

Initial improvement

Persistent/relapsing phase

Subset of patients

Most improve within days to weeks, but joint symptoms can persist for months or longer.

Slide 38 · Persistent chikungunya arthropathy

Longer-term symptoms may include arthralgia, arthritis or tenosynovitis.

Persistent pain does not establish continued viral replication in the joint.

Functional impairment can be considerable in some patients.

Assess other inflammatory and degenerative conditions when symptoms persist.

Slide 39 · Chikungunya testing depends on day of illness

Clinical timing

Preferred approach

Interpretation caution

First 8 days

Serum RT-PCR often detects viral RNA

Sensitivity changes as viraemia declines

From end of first week

Virus-specific IgM testing

IgM may persist; False positives occur

Uncertain early negative

Consider convalescent specimen

Use compatible history and local testing advice

Slide 40 · Chikungunya versus dengue

Feature

Chikungunya

Dengue

Typical joint syndrome

Often severe arthralgia or arthritis

Arthralgia; True synovitis less typical

Clinical emphasis

Debilitating polyarthralgia

Watch for bleeding, leakage and shock

Shared features

Fever, headache and rash

Fever, headache and rash

Safety priority

Exclude dengue when epidemiologically plausible

Avoid NSAIDs until dengue excluded

Slide 41 · Other alphaviruses: An exposure lesson

Ross River virus can cause joint symptoms with rash and constitutional illness.

Sindbis, Mayaro and O’nyong-nyong viruses cause regional arthritogenic syndromes.

The geographic range of arboviruses changes with outbreaks and vector ecology.

Use location-specific public health guidance; One broad “tropical virus panel” is rarely optimal.

Slide 42 · Rubella: Arthropathy in systemic infection

Acquired rubella may present with rash, fever and lymphadenopathy.

Arthritis or arthralgia is particularly associated with infection in adult women.

Vaccination has reduced rubella-associated disease in many settings.

Consider rubella according to exposure, immunization and public health context.

Slide 43 · Rubella: Why pregnancy status matters

Infection during pregnancy can cause congenital rubella syndrome.

Suspected rubella requires appropriate infection-control and public health action.

A rash–arthritis syndrome in a pregnant person warrants prompt professional assessment.

The rheumatologic symptom is not the principal determinant of fetal risk.

Slide 44 · Epstein–Barr virus: Avoid over-attribution

EBV is listed by Robbins among viruses associated with arthritis.

When present, arthralgia may occur with a compatible systemic illness.

True EBV-attributable inflammatory arthritis is less well characterized than parvovirus or alphavirus disease.

Positive past-exposure serology alone cannot establish the cause of current synovitis.

Slide 45 · HIV and other viruses: Contextual expansion

Acute HIV infection may cause arthralgia during a systemic retroviral illness.

In patients with HIV, arthritis may reflect coinfection, reactive arthritis or immune reconstitution.

Rarely implicated agents also include HTLV-1 and other viral infections.

Include these causes only when risk, systemic manifestations and epidemiology justify testing.

Slide 46 · First task: Identify danger, not a virus

Acute painful/swollen joint

Concern for septic arthritis?

Hot monoarthritis · toxicity · risk factors

If lower immediate risk:

Pattern + exposure + targeted testing

Urgent aspiration and assessment

Reassess if persistent or atypical

Slide 47 · A hot joint requires urgent evaluation

Acute hot swollen monoarthritis is septic arthritis until adequately assessed.

Fever may support infection but is not obligatory.

Deferral of joint aspiration can delay recognition of destructive bacterial disease.

Viral serology must not replace urgent microbiologic assessment when septic arthritis is plausible.

Slide 48 · When aspiration is appropriate

Acutely swollen unexplained joints, especially monoarthritis, often warrant arthrocentesis.

Synovial cell count/differential, Gram stain, culture and crystal analysis address key urgent differentials.

A sterile inflammatory aspirate does not specifically diagnose viral arthritis.

Clinical judgment determines whether additional microbiologic studies are necessary.

Slide 49 · History: Four domains with high yield

Context / findings

Time relation: Systemic illness before, with or after joint symptoms

Joint count and distribution: Mono-, oligo- or polyarthritis

Diagnostic implication

Exposure: Childcare, travel, mosquitoes, sexual or blood-borne risk

Context: Pregnancy, immunosuppression, vaccine status and chronic hepatitis

Slide 50 · Examination: Establish inflammation

Document swollen joint count, joint warmth and effusion.

Distinguish restricted active movement from restricted passive movement.

Look for rash, lymphadenopathy, hepatomegaly, purpura or other systemic clues.

Assess for signs of septic arthritis and clinically significant extra-articular disease.

Slide 51 · Basic laboratory investigations

CBC, inflammatory markers and liver tests can characterize systemic illness, but are nonspecific.

Transaminase elevation raises consideration of hepatitis or systemic arboviral illness.

Cytopenias may arise in viral infection; Interpret them in the total clinical picture.

Testing should answer a clinical question rather than replace history and examination.

Slide 52 · Targeted etiologic testing

Candidate

Context for testing

Illustrative test

Parvovirus B19

Acute compatible polyarthritis/exposure

B19 IgM; Selected PCR

Chikungunya

Relevant travel, vector exposure, acute fever

Early RT-PCR; Later IgM

HBV / HCV

Hepatitis clues or relevant risk

HBV panel; Anti-HCV with reflex RNA

Rubella

Compatible illness/public health setting

Testing coordinated with public health

Slide 53 · Test timing changes what a result means

Symptom onset

Early viraemia

Nucleic acid often best

Seroconversion

IgM emerges

Later phase

Prior exposure may confound

This principle is pathogen-dependent; Apply the specific validated testing window.

Slide 54 · Three frequent interpretation errors

Calling any IgG-positive patient a current viral-arthritis case.

Treating low-titre RF/ANA as definitive evidence of chronic autoimmunity.

Assuming a positive viral test proves causality when another joint disorder may coexist.

Failing to revisit the diagnosis when synovitis persists.

Slide 55 · Joint biopsy is not a routine viral test

Synovial histology may show inflammation but generally lacks a pathogen-specific pattern.

Routine tissue sampling is not needed for most straightforward transient viral syndromes.

Biopsy or specialized testing is reserved for selected atypical or persistent presentations.

Do not depict generic lymphocytic synovitis as diagnostic proof of a particular virus.

Slide 56 · Imaging: Purpose and limits

Plain radiographs may help assess joint damage or competing pathology.

Ultrasound can demonstrate synovitis or effusion and guide aspiration.

Inflammatory imaging findings do not determine which virus, if any, is responsible.

Erosive progressive disease should prompt reconsideration of a simple viral explanation.

Slide 57 · Viral arthritis versus rheumatoid arthritis

Clue

Viral arthritis

Rheumatoid arthritis

Onset

Often abrupt with infection clues

Persistent inflammatory course

Distribution

Can be symmetric and small-joint

Frequently symmetric small-joint

Serology

Transient RF/ANA possible

Disease-specific findings may support RA

Follow-up

Often improves over weeks

Untreated persistent synovitis may progress

Slide 58 · Viral versus reactive arthritis

Feature

Virus-associated arthritis

Reactive arthritis

Trigger

Viral illness

Typically preceding gastrointestinal or genitourinary infection

Dominant joint pattern

Often symmetric polyarthritis

Often asymmetric lower-limb oligoarthritis

Associated features

Rash, hepatitis or viral syndrome

Possible enthesitis, urethritis or conjunctivitis

Testing focus

Targeted viral workup

Search for triggering infection, clinical syndrome

Slide 59 · Viral versus pyogenic septic arthritis

Feature

Viral arthropathy

Bacterial septic arthritis

Presentation

Often multiple joints; Systemic viral clues

Frequently acute very painful swollen joint

Urgency

Variable; Assess danger first

Time-critical emergency

Synovial culture

Usually unrevealing for bacteria

May identify bacterial pathogen

Management priority

Targeted/supportive after assessment

Urgent aspiration, antibiotics and source control

Slide 60 · Viral versus crystal-induced arthritis

Feature

Viral syndrome

Crystal arthritis

Typical clinical context

Temporal viral/exposure clues

Sudden inflammatory flare

Pattern

Often polyarticular

Often mono- or oligoarticular

Diagnostic evidence

Appropriate viral assays in context

Characteristic crystals on microscopy

Important caveat

Viral serology does not exclude crystals

Crystals do not exclude concurrent infection

Slide 61 · An integrated clinical decision pathway

Acute painful/swollen joint

Concern for septic arthritis?

Hot monoarthritis · toxicity · risk factors

If lower immediate risk:

Pattern + exposure + targeted testing

Urgent aspiration and assessment

Reassess if persistent or atypical

Slide 62 · Treatment is syndrome-specific

Exclude serious alternate diagnoses before labeling a syndrome viral.

Most uncomplicated viral arthritides require supportive management.

Appropriate analgesia, activity modification and reassessment are central.

Avoid indiscriminate immunosuppression when an active infection remains possible.

Slide 63 · Supportive versus pathogen-directed care

Setting

Principal treatment concept

Caution

Uncomplicated B19 / rubella

Supportive symptom control

Risk groups require added assessment

Suspected chikungunya

Supportive treatment and follow-up

Exclude dengue before NSAIDs

Chronic active HCV

Direct-acting antiviral assessment

Evaluate immune-complex complications

HBV-associated disease

Manage HBV based on infection status

Coordinate with hepatology when indicated

Slide 64 · Persistent symptoms merit reassessment

Reassess objectively for synovitis, functional limitation and new systemic findings.

Consider post-chikungunya inflammatory symptoms and concomitant RA or other disease.

Evaluate hepatitis-associated immune-complex manifestations when clinically suggested.

Escalate to rheumatology, infectious disease or hepatology based on dominant pathology.

Slide 65 · Clinical vignette: New small-joint polyarthritis

A previously well adult develops abrupt symmetric wrist and MCP pain over five days. A child at home recently had a febrile rash. There are no erosive changes and no history of chronic inflammatory joint disease.

Which viral cause should be prioritized—and what would support a recent infection?

Slide 66 · Vignette interpretation: Parvovirus B19

Child exposure and acute RA-like distribution strongly support B19 as a candidate.

B19 IgM, interpreted with onset and clinical context, can support recent infection.

RF positivity alone would not establish rheumatoid arthritis.

Repeat clinical assessment if synovitis persists or atypical features emerge.

Slide 67 · Clinical vignette: Acute fever after travel

A traveler returns from an area with Aedes-borne transmission. Abrupt fever, diffuse rash and disabling symmetric polyarthralgia develop within days. The patient is still in the first week of illness.

Which arbovirus is prominent, which dangerous alternative matters, and which test is time-appropriate?

Slide 68 · Vignette interpretation: Chikungunya

Chikungunya is a strong consideration because of severe febrile polyarthralgia and exposure.

Dengue must remain in the differential, especially before using NSAIDs.

Acute-phase serum RT-PCR for chikungunya is reasonable during the early testing window.

Persistent arthritis requires follow-up rather than automatic assumption of continuing viraemia.

Slide 69 · Clinical vignette: Arthritis with purpura

An adult with chronic hepatitis C develops arthralgia, palpable leg purpura and peripheral neuropathic symptoms. Complement testing shows a low C4.

What mechanism best links the joint complaints with the systemic findings?

Slide 70 · Vignette interpretation: Immune complexes

The findings are compatible with HCV-associated mixed cryoglobulinemic vasculitis.

Immune-complex vascular injury explains why symptoms extend beyond synovium.

Assess HCV RNA, cryoglobulins and organ involvement using appropriate testing procedures.

Treatment planning should address viral infection and the severity of systemic vasculitis.

Slide 71 · Synthesis: Map mechanism to phenotype

Example

Mechanistic emphasis

Phenotypic clue

Rubella / some alphaviruses

Direct joint infection can contribute

Systemic viral illness with arthritis

Parvovirus B19

Host immune response implicated

Acute RA-like small-joint syndrome

Acute HBV

Immune-complex injury

Prodromal rash–arthritis syndrome

Chronic HCV

Persistent immune activation

Arthritis plus cryoglobulinemic vasculitis

Slide 72 · High-yield conclusions

Viral arthritis is a syndrome: Identify the virus and its clinical context, not merely joint pain.

Two major mechanisms are direct joint infection and infection-associated immune inflammation.

Parvovirus, hepatitis B/C and alphaviruses produce recognizably different clues.

Exclude septic arthritis, test selectively and reconsider persistent synovitis.

Slide 73 · Core references and provenance

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Elsevier; 2026.

Marks M, Marks JL. Viral arthritis. Clin Med (Lond). 2016;16:129–134.

CDC: Parvovirus B19; Chikungunya clinical signs/testing; Rubella symptoms and complications.

Supplementary review: HCV rheumatic manifestations (World J Gastroenterol, 2016).